Ryan Griffin

Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post hoc analysis

Emily R. Hankosky, Hui Wang, Lisa M. Neff et al. · Diabetes Obesity and Metabolism · 2023 · 89 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Body composition changes during weight reduction with tirzepatide in the <scp>SURMOUNT</scp> ‐1 study of adults with obesity or overweight

Michelle Look, Julia P. Dunn, Robert F. Kushner et al. · Diabetes Obesity and Metabolism · 2025 · 85 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +16

Impact of Enteral Methadone on the Ability to Wean off Continuously Infused Opioids in Critically Ill, Mechanically Ventilated Adults: A Case-Control Study

Nada S. Al‐Qadheeb, Russel J. Roberts, Ryan Griffin et al. · Annals of Pharmacotherapy · 2012 · 33 citations

Nursing, Pharmacology, Pharmacotherapy +12

Recruiting Primary Care Physicians to Teach Medical Students in the Ambulatory Setting

Gerald D. Denton, Ryan Griffin, Pedro Cazabon et al. · Academic Medicine · 2015 · 25 citations

Medicine, Medical Education, Clinical Medicine +7

Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the <scp>SURMOUNT</scp> ‐1 to ‐4 trials

Domenica Rubino, Sue D. Pedersen, Lisa Connery et al. · Diabetes Obesity and Metabolism · 2025 · 17 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16